# Study to Evaluate the Safety of Treatment With A"LLERGOVAC® HIMENÓPTEROS" in Patients Sensitized to This Venom

> **NCT04112797** · — · UNKNOWN · sponsor: **Roxall Medicina España S.A** · enrollment: 50 (estimated)

## Conditions studied

- Allergy to Himenoptera Venom

## Interventions

- **BIOLOGICAL:** Allergovac himenoptera

## Key facts

- **NCT ID:** NCT04112797
- **Lead sponsor:** Roxall Medicina España S.A
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-05-23
- **Primary completion:** 2023-11
- **Final completion:** 2023-11
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2022-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04112797

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04112797, "Study to Evaluate the Safety of Treatment With A"LLERGOVAC® HIMENÓPTEROS" in Patients Sensitized to This Venom". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04112797. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*